Xeris Biopharma Holdings (XERS) EPS (Basic) (2020 - 2026)
Xeris Biopharma Holdings (XERS) posted EPS (Basic) of $0.01 for Q1 2026, down 81.03% on a QoQ basis from $0.07 in Q4 2025, and up 121.66% year-over-year from $0.01 in Q1 2025.
Xeris Biopharma Holdings (XERS) EPS (Basic) (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at $0.01 for Q1 2026.
- Quarterly EPS (Basic) rose 121.66% year-over-year to $0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.07 (up 123.82% YoY) and the FY2025 annual result came in at $0.0, up 100.92% from the prior year.
- EPS (Basic) was $0.01 for Q1 2026 at Xeris Biopharma Holdings, down from $0.07 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.07 in Q4 2025 and bottomed at -$0.25 in Q1 2022.
- A 5-year average of -$0.09 and a median of -$0.1 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) declined 19.64% — and 2025, when it soared 298.28%.
- Xeris Biopharma Holdings' EPS (Basic) stood at -$0.1 in 2022, then declined by 2.02% to -$0.1 in 2023, then soared by 64.18% to -$0.03 in 2024, then surged by 298.28% to $0.07 in 2025, then tumbled by 81.03% to $0.01 in 2026.
- Business Quant data shows XERS's EPS (Basic) at $0.01 in Q1 2026, $0.07 in Q4 2025, and $0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Xeris Biopharma Holdings | 1.43 Bn | 1.32 Bn | 72.55 Mn | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.12 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.19 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.39 |
| Jun 30, 2021 | -0.41 |